Myers Donna I, Poole Lynn J, Imam Khursheed, Scheel Paul J, Eustace Joseph A
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Am J Kidney Dis. 2003 Feb;41(2):351-9. doi: 10.1053/ajdk.2003.50043.
The variable course of renal disease in type 2 diabetes mellitus in part may reflect associated atherosclerotic nephropathy.
To determine the influence of subcritical (<65%) renal artery stenosis (RAS) on the progression of chronic kidney disease, 45 patients with type 2 diabetes with uncontrolled hypertension and serum creatinine levels of 1.8 mg/dL or greater (>/=159.1 micromol/L) were screened by three-dimensional magnetic resonance angiography (MRA). Mean monthly decrease in reciprocal serum creatinine x 100 and time to initiation of dialysis therapy, adjusting for baseline serum creatinine level, were compared in those with and without RAS. Follow-up was censored at the time of death or angioplasty.
At baseline, RAS-negative (RAS(-); n = 27) and RAS-positive (RAS(+); n = 18) groups were similar in duration of diabetes and hypertension, hyperlipidemia, blood pressure, diabetic management, and renal function. RAS(+) subjects were older (P = 0.04) and more likely to have claudication (P = 0.006), smoke (P = 0.02), and have heart disease (P = 0.06). During a median follow-up of 9.4 months, 3 patients underwent stent placement, 2 patients died, and 12 patients progressed to dialysis therapy. The RAS(+) group had a more rapid monthly decline in reciprocal serum creatinine x 100 (mean, 1.63 +/- 0.9 versus 0.69 +/- 1.0 [SD]; P = 0.04). The relative risk for progression to end-stage renal disease was 2.4 in the RAS(+) versus RAS(-) group. Multivariate analysis showed that this effect was not independent of several established atherosclerotic risk factors.
MRA-detected RAS is common (40%) in patients with type 2 diabetes with uncontrolled hypertension and renal insufficiency. Subcritical (<65%) RAS is a significant risk factor for progressive renal failure.
2型糖尿病患者肾病病程多变,部分原因可能是合并动脉粥样硬化性肾病。
为确定亚临界(<65%)肾动脉狭窄(RAS)对慢性肾病进展的影响,对45例2型糖尿病且高血压未得到控制、血清肌酐水平为1.8 mg/dL或更高(≥159.1 μmol/L)的患者进行三维磁共振血管造影(MRA)筛查。比较有或无RAS患者的血清肌酐倒数每月平均下降值×100以及开始透析治疗的时间,并根据基线血清肌酐水平进行校正。随访在死亡或血管成形术时进行截尾。
基线时,RAS阴性(RAS(-);n = 27)和RAS阳性(RAS(+);n = 18)组在糖尿病和高血压病程、高脂血症、血压、糖尿病管理及肾功能方面相似。RAS(+)患者年龄较大(P = 0.04),更易出现跛行(P = 0.006)、吸烟(P = 0.02)和患有心脏病(P = 0.06)。在中位随访9.4个月期间,3例患者接受了支架置入,2例患者死亡,12例患者进展至透析治疗。RAS(+)组血清肌酐倒数每月下降更快(平均值,1.63±0.9对0.69±1.0[标准差];P = 0.04)。RAS(+)组进展至终末期肾病的相对风险是RAS(-)组的2.4倍。多变量分析显示,这种影响并非独立于几种已确定的动脉粥样硬化危险因素。
MRA检测到的RAS在2型糖尿病且高血压未得到控制及肾功能不全的患者中很常见(40%)。亚临界(<65%)RAS是进行性肾衰竭的重要危险因素。